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Abstract
Background: International travel and migration have been related with an increase of imported malaria
cases. There has been considerable immigration to Barcelona from low-income countries (LIC) in recent
years. The objective is to describe the epidemiology and to determine the trends of the disease in
Barcelona.
Methods: Analysis of the cases notified among city residents between 1989 and 2005. Patients were
classified as: tourists, voluntary workers, resident immigrants (visiting friends and relatives, VFR) and
recently arrived immigrants. An analysis was conducted using the chi2 test and comparison of means. As a
measure of association we calculated the Relative Risk (RR) and Odds Ratio (OR) with a Confidence
Interval of 95% (CI) and carried out a trends analysis.
Results: Of the total of 1,579 imported cases notified, 997 (63.1%) lived in Barcelona city, and 55.1% were
male. The mean age of patients was 32.7 years. The incidence increased from 2.4 cases/100,000 in 1989
to 3.5 cases/100,000 in 2005 (RR 1.46 CI:1.36–1.55). This increase was not statistically significant (trends
analysis, p = 0.36). In terms of reason for travelling, 40.7% were VFR, 33.6% tourists, 12.1% voluntary
workers and 13.6% were recently arrived immigrants. The most frequent species found was Plasmodium
falciparum (71.3%), mainly in visitors to Africa (OR = 2.3, CI = 1.7–3.2). The vast majority (82.2%) had had
some contact with Africa (35.9% with Equatorial Guinea, a Spanish ex-colony) and 96.6% had not
completed chemoprophylaxis. Six deaths were observed, all tourists who had travelled to Africa and not
taken chemoprophylaxis (3.9% fatality rate).
Conclusion: Over the period studied there is an increase in malaria incidence, however the trend is not
statistically significant. Lack of chemoprophylaxis compliance and the association between Africa and P.
falciparum are very clear in the imported cases. Most of the patients with malaria did not take
chemoprophylaxis.
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Background
Malaria is an infectious disease caused by an intracellular
protozoan parasite of the genus Plasmodium and is trans-
mitted by the bite of the female Anopheles mosquito. It is
endemic in more than 100 countries and mainly concen-
trated in the tropics and some subtropical areas. Transmis-
sion varies between regions and between urban zones and
it is estimated that the population that lives in risk-zones
will continue to increase [1-3]. Currently, there are still
350–500 million new cases and more than one million
deaths per year [1,4-6], 90% of which occur in Africa.
Malaria has been identified as the disease with the greatest
impact on morbidity in the world, contributing to the
obstruction of social and economical development in
many countries [3-6].
Malaria was eradicated from Europe in the seventies. In
Spain, the last autochthonous case was diagnosed in 1961
and the official certificate of eradication was obtained in
1964. All of the diagnosed cases are imported with the
exception of a few particular forms of transmission of
malaria in airports and transmission via blood, in transfu-
sions and between intravenous drug users [7]. The
increase of international travel and immigration from
endemic zones has caused an increase in the number of
recorded cases in the last few years. Between 13,000 and
16,000 cases are notified annually in Europe (about 400
of the cases are from Spain) [8], with a fatality rate of
2–3% [2]. In Spain, malaria is also a notifiable disease. In
addition to the general observation of an increase in cases
between 1981 and 1987 [7], an increase has also been
reported by some health centres [9,10]. The objective of
the present study is to determine the epidemiological
characteristics and evolution of malaria during a 17-year
period in a city, which has experienced massive immigra-
tion from low-income countries (LIC) in recent years.
Methods
Study population
All of the notifications of malaria between January, 1989
and December 2005 were reviewed by the Epidemiology
Service of the Barcelona Public Health Agency. The study
included confirmed cases of malaria among Barcelona res-
idents notified during the period of the study. Cases of
any episode indicative of malaria confirmed in a labora-
tory were also considered, once possible relapse from a
previous episode had been ruled out.
Epidemiological survey
After every notification, a nurse filled out a questionnaire
which collected patients' personal information, and dates
of first symptoms, diagnosis, hospital admission and dis-
charge. The following information was also collected:
endemic geographical areas visited within 30 days prior to
onset of symptoms, or the last country visited if it
exceeded 30 days (Plasmodium vivax/Plasmodium ovale),
the reason for travel, and, in the case of an immigrant, if
they already resided in Barcelona or had only recently
arrived to the city. For analysis purposes, the immigrants'
children were also considered immigrants, even if they
were born in Barcelona. The information about comple-
tion of chemoprophylaxis treatment, and visited area
according to the level of risk of multi-resistant Plasmodium
falciparum  transmission, as defined by the WHO [11]
(Types I to IV: minimum to maximum level of recommen-
dation for prevention), was also noted.
Subjects were classified, based on birthplace and usual
place of residence, into one of four categories of traveller:
"tourists" (reside in a non-malaria country and went to an
endemic area for vacation or work), "volunteers" (born in
a non-malaria country, but reside in an area with
malaria), and immigrants, subdivided into "visiting
friends and relatives (VFR)" (born in areas with malaria,
or their children born in Barcelona, who reside in an area
without malaria and travel to their country of origin to
visit friends or family) [7,12] and "arriving immigrants".
The epidemiological survey allowed for differentiation
between VFR and those recently arriving immigrants.
Laboratory
The most relevant microbiological data were the type of
species detected and the method used for diagnosis. The
diagnostic criterion included the microscope observation
of parasites and identification of species on a Giemsa-
stained thick and thin bloodfilm. When the morphologi-
cal characteristics of parasites were indeterminate they
were considered Plasmodium sp.
Statistical analysis
The quantitative variables were described using mean and
standard deviation (SD), or median and interquartile
range (IR) if the data did not follow a normal distribution.
The chi square test was used to compare qualitative varia-
bles, while ANOVA and the corresponding non-paramet-
ric tests were used to compare the quantitative variables.
In looking for trends, the best straight line fit was deter-
mined and a chi square test of the trend was calculated.
For measures of association between different groups, a
bi-variate Odds Ratio (OR) and Relative Risk (RR) was cal-
culated with confidence intervals of 95% (CI) and logistic
regression was used at multivariate level to adjust for age
and sex.
The rates of incidence per 100,000 inhabitants in one year
were calculated using the average population in a five-year
period (there were 1,503,884 inhabitants in Barcelona in
the 2001 census) [13]. SPSS version 13.0 and EpiInfo ver-
sion 6 programs were used for statistical analysis.Malaria Journal 2008, 7:56 http://www.malariajournal.com/content/7/1/56
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Results
Incidences and trends
The study included 1,579 cases, all imported except one,
infected by transfusion. Barcelona city residents
accounted for 997 cases (63.1%) (Figure 1). The incidence
rates varied from 2.4/100,000 in 1989 to 3.5/100,000 in
2005, with a peak in 2000 (5.4/100,000) (Figure 2). The
specific rates for the population born in Barcelona
changed from 0.92 in 1991 to 1.47/100,000 in 2004 (RR
= 1.6; CI: 1.48–1.71). The rates among VFR decreased
from 64/100,000 in 1991 to 11.6/100,000 in 2004 (RR =
5.5; CI: 5.31–5.64) in the city. The trends analysis did not
reveal any significant increase over the years (p = 0.36),
even though the risk increased by almost 50% when com-
paring the years 1989 and 2005 (RR = 1.46; CI:
1.36–1.55). Thirty seven percent of the cases were notified
in the months of September, October, and December.
Group characteristics
The mean age was 32.7 years with SD of 15.7, and pre-
dominantly male (55.1%). Regarding the type of traveller,
40.7% were VFR, 33.6% tourists, 12.1% volunteers, and
13.6% recently arriving immigrants. A group could not be
assigned in 215 cases (21.6%). Compared with tourists,
the VFR were mainly young, had visited Africa, and did
not complete chemoprophylaxis (p < 0.001) (Table 1).
The annual trends in the number of cases by groups shows
a great increase among tourists (Figure 3). It was also
noted that 82.1% of the patients had travelled to an Afri-
can country (35.9% to Equatorial Guinea).
The vast majority of cases (83.2%) came from the only
two centres in Barcelona with Tropical Medicine Units,
the Hospital Clinic and the Drassanes Primary Health
Centre. Hospital admissions were required in 31.2% of
cases, most being admitted to the Hospital Clinic (59%).
The median length of stay was four days (IR 3–6). The
median time from onset of symptoms until diagnosis was
eight days (IR 5–20), nine days (5–23) among immi-
grants and 10 (6–25) among autochthonous patients (p =
0.35). P. falciparum infection was more prevalent in immi-
grants than autochthonous patients (OR = 2.1; CI:
1.6–2.9, p < 0.001), even though autochthonous patients
were admitted more often than the immigrants (OR = 1.8;
CI: 1.3–2.3, p < 0.001). One third of the immigrants (262,
33.5%), generally less severe cases, were treated at the
Drassanes Primary Health Centre.
A total of 120 cases (12%) were children under 15; 86.7%
were immigrants (OR = 2.6; CI: 1.4–4.8, p = 0.004), 91%
came from Africa, and 1% from America (p < 0.001);
69.8% were infected with P. falciparum.
Standardized rates were calculated for each district in the
city (data not shown). The highest annual incidence rate
was in Ciutat Vella (District 1), followed by Nou Barris
(District VIII) and Sarriá (District V) (rates of 10.1, 5.1,
and 4.7/100,000, respectively). A significant association
was observed between immigration and living in Nou
Barris (OR = 5.2; CI: 3.1–8.6, p < 0.001) or in Ciutat Vella
(OR = 2.3; CI: 1.5–3.3, p < 0.001) and between tourists
and living in Sarriá (OR = 2.4; CI: 1.5–3.9, p < 0.001).
Evolution of notified malaria cases in Barcelona according to notification year and place of residence (1989–2005) Figure 1
Evolution of notified malaria cases in Barcelona according to notification year and place of residence 
(1989–2005).
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Comparison of malaria rates and percentage of immigrants among the general population of Barcelona (1989–2005) Figure 2
Comparison of malaria rates and percentage of immigrants among the general population of Barcelona 
(1989–2005).
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Table 1: Epidemiological characteristics of the different groups of travelers affected by malaria in Barcelona (1989–2005).
Tourists N (%) Volunteers N (%) VFR N (%) Recently AI N (%) Total N (%) p-value*
Age (md, IR) 33 (27–41) 40.5 (31–57) 30 (21–39) 27 (24–41) 32.7 (15.7) 0.02
Sex
Male 161 (61.2) 46 (48.4) 171 (53.9) 55 (51.9) 433 (55.1) 0.001
Female 102 (38.8) 49 (51.6) 146 (46.1) 51 (48.1) 348 (44.9)
Duration of travel (md, IR) 30 (22–67) 88 (32–259) 31 (26–62) - 31 (25–81) 0.81
Correct CP
Yes 8 (4.5) 6 (10.4) 1 (0.4) - 15 (2.7) < 0.001
No 46 (25.8) 13 (22.4) 13 (5.3) 2 (2.9) 74 (13.4)
Not taken 124 (69.7) 39 (67.2) 231 (94.3) 68 (97.1) 462 (83.8)
Total 178 (32.3) 58 (10.5) 245 (44.5) 70 (12.7) 551 (100)
Continent
Asia 26 (10) 4 (4.2) 26 (8.2) 4 (3.8) 60 (7.7) 0.002
Africa 185 (70.6) 85 (89.5) 272 (85.8) 98 (92.4) 640 (82.1)
America 49 (18.7) 6 (6.3) 19 (6) 4 (3.8) 78 (10)
Oceania 2 (0.7) - - - 2 (0.2)
Total 262 (33.6) 95 (12.1) 317 (40.7) 106 (13.6) 780 (100)
md.: median, IR: interquartile range, CP: chemoprophylaxis, VFR: visiting friends and relatives, AI: arriving immigrants.
* comparison between VFR and tourists.
Laboratory
Plasmodium falciparum was the species most frequently
identified, in 614 cases (71.3%) (Table 2). The smear did
not reveal the species in 136 cases (13.6%), even though
parasite was detected by the thick drop test. In terms of
continents,  P. falciparum was isolated most frequently
from Africa (81.6%) (OR = 2.3; CI: 1.7–3.2, p < 0.001),
while P. vivax was the most frequent in travellers from Asia
(69.2%) (OR = 12.4; CI: 6.9–21.9, p < 0.001) and America
(71.3%) (OR = 16.7; CI: 9.9–28.2, p < 0.001). ProgressionMalaria Journal 2008, 7:56 http://www.malariajournal.com/content/7/1/56
Page 5 of 9
(page number not for citation purposes)
over time shows a clear prevalence of P. falciparum (Figure
4).
Chemoprophylaxis and lethality
Chemoprophylaxis was not taken or not completed cor-
rectly in 96.9% of the cases, while only 3.1% appeared to
complete it correctly. Regarding the distribution of chem-
oprophylaxis by zone, 90% of the cases had visited a
country with high risk of transmission of multi-resistant
P. falciparum (Type IV Risk) (Table 3). There were signifi-
cant differences between the groups of patients; tourists
had the best adherence (p < 0.001), in spite of overall low
compliance to chemoprophylaxis.
Six deaths were observed, all attributed to P. falciparum
(lethality rate of 1.05%) and all were tourists who had
travelled to Africa (3.9% fatality rate), 66.7% being male.
None had taken chemoprophylaxis. The average age of
those who died was 51.3 years (SD 13.5) and was 32.5
years (SD 13.6) for those who did not (p = 0.003).
Discussion
The increase in imported malaria cases from different
countries is due to the augment of immigration from LIC
and the number of people visiting endemic areas [5,6]. In
Barcelona, despite a significant increase in the number of
cases in the period 1981–1987 [7], and despite incidence
being higher in 2005 than in the preceding five years, the
trend observed in incidence was not statistically signifi-
cant. Moderate increases have also been observed in Cata-
Distribution of isolated species in Barcelona city between 1989 and 2005 by notification year Figure 4
Distribution of isolated species in Barcelona city between 1989 and 2005 by notification year.
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lonia and Spain [14], in various European cities [15-18],
the USA [19,20], and in Canada [21].
The rates of malaria observed in the autochthonous pop-
ulation were 1.5 times higher in 2004 than in 1991, prob-
ably due to increases in travel to endemic areas and failure
to comply with chemoprophylaxis. On the other hand,
the rate among the VFR group was more than five times
higher in 1991 than in 2004. This is probably because the
immigrant population registered in the 2004 census had
grown, due to extensive immigration occurring in Spain,
and the immigrants were primarily from Latin America
and Northern Africa, areas with low incidences, or entirely
free of malaria [13] (Figure 2). It is also possible that the
sub-Saharan VFR group – lowest in number but highest in
terms of risk of acquiring and importing malaria – do not
yet go back to their countries as often due to the high cost
of travel, precarious conditions and non-regularized resi-
dence status.
It is debatable if the impact of malaria at global level is
underestimated [22,23]. In this study, which relies on the
notifications from doctors, the number of cases could be
underestimated, as observed in London and the Nether-
lands [23-25]. However, there has been good collabora-
tion for many years between the Epidemiology Service
and the two reference centres for imported diseases, where
most of the cases in the city were visited and compiled. In
fact, the difference in rates among Barcelona, Catalonia,
and Spain (Figure 5) reflect not only the presence of high
tourism activity and immigration in Barcelona, but also a
better system of awareness, given the notable differences
in incidence.
Immigrants from sub-Saharan Africa classified as VFR, fol-
lowed by tourists, constitute the groups in Spain account-
ing for the highest numbers of cases [8,26,27], something
also seen in various European cities [12,17,18]. As
observed by other authors, these infected immigrants
have probably acquired semi-immunity, thus their mani-
festation is less serious (less hospitalizations and there are
no records of deaths), in contrast to the fatality observed
among tourists who visit Africa (3.9% fatality rate) [28].
The characteristics of the immigrant and autochthonous
subjects are very different. Whereas the immigrants, many
having migrated for economic reasons, normally go to
visit their families in areas with hyperendemic malaria, in
low-income countries, the other subjects are tourists who,
when they travel, stay for shorter periods, visit areas with
less endemic malaria, and take more precautions (have
less risk of mosquito bites through staying in air-condi-
tioned hotels, and adhere better to chemoprophylaxis).
However, one of the limitations of the study was that
twenty two percent of the patients could not be assigned
to a group because it was not known if they were recently
arriving immigrants or if they already lived in Barcelona
or, in the case of autochthonous patients, because the rea-
son for their travel, whether as a tourist or for volunteer
purposes, was not recorded.
Other countries with high immigration rates have also
observed a large number of imported malaria cases
Table 2: Malaria in Barcelona: Plasmodium species by continent visited.
Africa Asia America Oceania Unknown Total n (%)
P. falciparum 565 16 22 0 11 614 (71.3)
P. vivax 55 45 62 2 2 166 (19.3)
P. ovale 41 1 2 0 0 44 (5.1)
P. malariae 31 3 1 0 2 37 (4.3)
Plasmodium sp 80 8 3 0 45 136 (13.6)
Total 772 73 90 2 60 997 (100)
Table 3: Malaria in Barcelona 1989–2005: malaria risk and type of prevention (WHO, 2006) according to the different groups of 
patients.
Type of Prevention* Tourists Volunteers FVR Recently AI Total n(%)
I 1 0 1 0 2 (0,3)
II 37 8 2 0 47 (6)
III 16 2 3 1 22 (2,8)
IV 206 81 312 105 704 (90)
Unknown 3 4 0 0 7 (0,9)
Total n (%) 263 (34) 95 (12) 318 (41) 106 (14) 782 (100)
VFR: visiting friends and relatives, AI: arriving immigrants.
* Depending on malaria risk in the area visited, the recommended prevention method may be mosquito bite prevention only (Type I), or mosquito 
bite prevention in combination with chemoprophylaxis (Type II to IV according to the P. falciparum presence and resistance in the area) [11].Malaria Journal 2008, 7:56 http://www.malariajournal.com/content/7/1/56
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among VFR [16]. These immigrants visit their homeland
with their children, rarely or never exposed to the disease
and consequently less likely to possess natural acquired
immunity, and none of them take (or if they take it, do
not complete) chemoprophylaxis. In Barcelona, where
the immigration boom is recent, the VFR cases could
increase in the future when immigrants and their children
have the opportunity to visit their mother country. It is
interesting to note that in this study the majority of the
affected minors were children of immigrants from sub-
Saharan Africa [10,27] and less of the affected minors
were from families from South America, a region of lower
malaria prevalence. It is also noteworthy that a great
number of the cases are either immigrants from the Span-
ish ex-colony Equatorial Guinea or their children, as seen
in the past [29]. Like many of the VFR, Equatorial Guin-
ean subjects, as well as their children and other family
members, continue to travel to their country without
undertaking chemoprophylaxis. When they come back,
despite being asymptomatic, they go for a check up at the
Drassanes PHC and hence many cases were detected
through screening. Indeed, if friends or relatives come to
visit them from Equatorial Guinea, they sometimes take
them to the doctor too. This could explain why so many
cases of falciparum malaria present in the specialized
health centre of the poorest district of the city. More stud-
ies are needed in order to better characterize this popula-
tion at a high risk of importing malaria.
The most affected districts within the city are those that
are most socio-economically disadvantaged and that
experienced the most immigration (Nou Barris and Ciutat
Vella) [13]. The district with the highest socio-economic
level (Sarria) is the third most affected, probably due to
the influence of tourists and volunteer workers. To
decrease malaria among VFR and their children, it is fun-
damental to make chemoprophylactic drugs more afford-
able and improve the awareness of the disease and the
information provided to travellers in the tropical health
centres.
Plasmodium falciparum continues to be the most frequent
species [9,10] in Barcelona as well as Spain in general [7],
other European countries [17,18], and the USA [19,20].
However, P. vivax is prevalent in England and Australia
[30] because the immigration in these countries is from
Asia, where P. vivax is the most common species. The
number of non-identified species (Plasmodium sp) can be
explained in part by the inexperience of some centres and
the high percentage of immigrants with very low parasi-
taemias, in which it is sometimes difficult to determine
the species. Nevertheless, the non-identified species were
clustered in the first few years of the study (Figure 4). The
existence of Plasmodium sp could correspond to sub-clini-
cal parasitaemia among semi immune immigrants from
holoendemic malaria areas. Nowadays, the incorporation
of a second generation of rapid diagnostic tests combining
aldolase and histidine-rich protein II (HRP-2) and PCR
would help to improve determination of the species.
Evolution of malaria rates notified in Barcelona, Catalonia and Spain (1989–2005) Figure 5
Evolution of malaria rates notified in Barcelona, Catalonia and Spain (1989–2005).
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The efficacy of chemoprophylaxis is a concern on a world-
wide scale. Despite resistances, the different chemoproph-
ylaxis guidelines could be effective [31], but there is a lack
of awareness of the observed problem [32] and adherence
is often inadequate [33], as seen in this study, particularly
among immigrants since under 0.5% of VFR subjects fol-
lowed recommendations. Compliance with chemoproph-
ylaxis among those affected between 1989 and 2005 was
lower than those affected between 1981 and 1987 [7], a
phenomenon observed in other contexts as well [17-19].
Speculating 90% efficacy of chemoprophylaxis and 90%
adherence, malaria could have been avoided in more than
294 of the 344 autochthonous cases.
Malaria in travellers is preventable if adequate measures
are taken. The WHO calculates that between 1995 and
2015, the number of long distance trips will have dou-
bled. In addition to the increase of risk of infection from
more travel to endemic areas, the growth of resistance to
medication should be considered, given the infrequent
and poor use of chemoprophylaxis [34,35]. Some of the
keys to the fight against this disease and its sometimes
fatal consequences [36] include early diagnosis and treat-
ment when a febrile syndrome is presented after a trip
[37], more and better adherence to chemoprophylaxis
[18,38], adjustment of drug doses such as primaquine to
avoid relapses [39,40] and extending the use of repellents,
impregnated clothes and mosquito nets [8,35]. Notifica-
tion of cases in the public health system is also an essen-
tial tool in order to follow the tendencies of this
important imported disease.
Some especially vulnerable groups will be exposed to the
disease and its complications in the next few years, such as
children, pregnant women [41], VFR (particularly in
Spain where many of the immigrants from Africa are
Equatorial Guineans), long term and elderly travellers
[35,42,43]. The use of chemoprophylaxis and the charac-
teristics of the most affected groups should be further
researched and the aforementioned recommendations
should be evaluated.
The high number of patients collected for this study was
possible thanks to the collaboration during the years of
the two centres of imported diseases and the epidemiol-
ogy service of Public Health Agency of Barcelona. The
joint work of the various health centres and public health
services, as done in related diseases concerning immigra-
tion such as tuberculosis [44], is a course that should be
followed. For the control and prevention of malaria, sur-
veillance must improve in cities and developed countries
because apart from better control, this could be a good
reflection of the disease worldwide.
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